Research Disclosures & Disclaimers

This website contains disclosures and disclaimers related to
published UBS Global Research products, including those related to
regulation, potential conflicts of interest as well as those provided
by third-party data providers describing limitations on use of their
products.

Centrica (CNA.L)*

UBS Rating and Price Target History Chart

Line chart explaining Price target vs Stock Price is described in below table

EQ Rating & Price Target Table

Date Stock Price (p) Price Target (p) Rating
2023-06-16119125Neutral
2023-07-03125135Neutral
2023-10-03150145Neutral
2023-12-11144165Neutral
2024-05-08134170Buy
2024-08-01130175Buy
2025-05-27156180Buy
2025-07-22164-No Rating
2025-07-23159180Buy
2025-07-30162200Buy
2025-09-11157205Buy
2025-12-17166200Buy
2026-03-24198230Buy
2026-07-03173220Buy
2026-07-30153205Buy

Disclosures

  • UBS acted as adviser to Centrica PLC on its 15% investment into the Sizewell C project. At announcement, HM Government will own 44.9%, Centrica 15%, EDF 12.5%, La Caisse 20% and Amber Infrastructure 7.6%
  • Within the past 12 months, UBS has received compensation for investment banking services from this company/entity or one of its affiliates.
  • This company/entity is, or within the past 12 months has been, a client of UBS Securities LLC and/or its affiliates, and investment banking services are being, or have been, provided.
  • Within the past 12 months, UBS has received compensation for products and services other than investment banking services from this company/entity.
  • UBS beneficially owned 1% or more of a class of this company's common equity securities as of last month's end (or the prior month's end if this report is dated less than 10 days after the most recent month's end).
  • UBS AG London Branch acts as broker to this company.
  • UBS holds a long position of 0.5% or more of the listed shares of this company.
Note : Historical Price Targets have been adjusted to account for any stock splits, rights issues and/or dividends which may have occurred for this security. Not Priced: Stock was not priced on the given date. No Rating: Issuer was not rated by UBS on the given day. No Price Target: For this issuer no Price Target was set by UBS on the given day. Issuers with an EQ Rating & Price Target Table are covered by UBS-IB Equity Research Analysts. Issuers without an EQ Rating & Price Target Table are not single stock covered.

* Issuers marked with an asterisk are covered by UBS-IB Equity Research Analysts. Issuers without an asterisk are not single stock covered.